Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-089075
Filing Date
2014-03-07
Accepted
2014-03-07 16:07:02
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d645073d10k.htm 10-K 1219110
2 EX-23.1 d645073dex231.htm EX-23.1 1562
3 EX-31.1 d645073dex311.htm EX-31.1 9428
4 EX-31.2 d645073dex312.htm EX-31.2 9415
5 EX-32.1 d645073dex321.htm EX-32.1 3142
6 EX-32.2 d645073dex322.htm EX-32.2 3198
13 GRAPHIC g645073g50w24.jpg GRAPHIC 70282
  Complete submission text file 0001193125-14-089075.txt   6903719

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT achn-20131231.xml EX-101.INS 905036
8 XBRL TAXONOMY EXTENSION SCHEMA achn-20131231.xsd EX-101.SCH 64140
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achn-20131231_cal.xml EX-101.CAL 70738
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achn-20131231_def.xml EX-101.DEF 371432
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE achn-20131231_lab.xml EX-101.LAB 486885
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achn-20131231_pre.xml EX-101.PRE 436113
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33095 | Film No.: 14677232
SIC: 2834 Pharmaceutical Preparations